pharmacie et médicaments – Remboursement du traitement anti-migraineux dit anti-CGRP

This written question asks about the conditions for reimbursement of a specific anti-migraine treatment that targets CGRP. It seeks clarification on the national policy regarding access to this type of medication. The question affects patients suffering from migraines and healthcare providers involved in prescribing and dispensing these treatments. It could influence future decisions on drug pricing and accessibility.